Status:
ACTIVE_NOT_RECRUITING
Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis
Lead Sponsor:
Mayo Clinic
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
MRI has been shown to be helpful in identifying patients who present with undifferentiated inflammatory arthritis who will develop RA within a one year follow up period. The absence of other clinicall...
Eligibility Criteria
Inclusion
- ≥ 18 years old
- Undifferentiated inflammatory arthritis suspected to be early RA (≥1 joint with synovitis and ≥1 other tender joint)
- Symptom duration ≤1 year
Exclusion
- Unwillingness or inability to return to Mayo Clinic Rochester for research follow-up visits
- Current or previous use of DMARDS
- Taking ≥10 mg of prednisone a day
- Contraindications to contract enhanced MRI
- History of another definite autoimmune or inflammatory rheumatic disease
- History of psoriasis
- History of inflammatory bowel disease
- Unsuitably as deemed by the principal investigator
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03841279
Start Date
January 1 2019
End Date
December 1 2025
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905